How do I combine equity and revenue-based financing in a SaaS company?

A founder with $3M in ARR and a working outbound motion is spending $0.80 in sales and marketing for every $1 of new ARR booked, and the constraint is not the market or the product. The constraint is that hiring the next two account executives costs $400K before it returns anything, and the company does not have $400K sitting idle.

That is a financing problem. It gets solved with equity about half the time, and every one of those times is a mistake, because selling 15% of the company to fund a hire whose return is already measurable is the most expensive money available. A lender will fund a proven motion at a known cost. An equity investor will fund it at a cost you find out about at exit.

The rule underneath the two instruments

Debt buys more of what already works. Equity buys something that does not exist yet.

The test is whether you can name what the next dollar returns and roughly when. Two more account executives at a known ramp and a known quota is a knowable return, so the correct instrument is debt or cash flow. A second vertical, a platform rebuild, a leadership team the company has never had, or an acquisition are all unknowable on that horizon, take eighteen months to appear in revenue, and no lender will touch them. Those are equity problems and they are worth dilution.

Founders who invert this pay equity prices for working capital and then find, two years later, that the real change the company needed now has to be funded from a much smaller ownership stake.

What has to be true before you borrow

A lender is not underwriting your ambition. It is underwriting the durability of revenue you already have, and there are four things it reads first.

Net revenue retention, above 90% and preferably above 100%. This single number does more to set the facility size and the price than anything else, because it tells the lender whether the revenue securing the loan will still be there in year three.

An ARR schedule that reconciles to the general ledger, monthly, with logos and expansion and churn broken out. Most diligence failures at this stage are reconciliation failures rather than performance failures. A founder who cannot tie ARR to revenue recognized in the ledger has not lost the loan on the merits; they have lost it on bookkeeping.

Gross margin computed after implementation and support costs. Vertical software carries services revenue and services cost, and a lender that discovers a 40% blended margin behind a claimed 85% subscription margin reprices everything. The unit economics play does this the way a lender will.

A contract register with terms, renewal dates, assignment clauses, and termination rights. Concentration is fine. But hidden concentration is not. If one customer is 22% of revenue on a contract terminable in thirty days, the lender needs to know before it finds out.

Covenant arithmetic, before the term sheet

Covenants are where non-dilutive capital turns dangerous, and the danger is almost always calibration rather than the covenant itself.

A minimum ARR covenant set at plan converts an ordinary 15% miss into a default. Set against trailing twelve-month performance with headroom, the same covenant is a reasonable guardrail. Push for the second and model the first: build the cash flow forecast in a downside case and find the month a covenant breaks. If a plausible bad quarter breaches, the covenant is wrong, not the quarter.

Then read the cure. A covenant with a thirty-day cure and an equity cure right is survivable. One with no cure hands the lender the keys on a bad month, and a lender holding the keys in year two of a five-year facility has different interests than you do.

Running both together

The blend most vertical software companies should end up with looks like this in practice. Ordinary growth spend comes from operations, governed by a real budget. A debt facility funds the proven motion and gets refinanced upward as ARR grows and the price falls, which is the compounding described in the SaaS Capital Flywheel. A single minority equity round funds the one structural change, sized to that change rather than to a round.

Firms that do both sides exist and there are not many. The category includes lenders that added small equity programs, growth funds that added credit vehicles, and a handful of firms like Golden Section that run growth equity and lending as separate underwriting with separate committees. The separation matters. A founder should be able to borrow without being nudged toward selling equity, and the way to find out is to ask whether the two decisions are made by the same people.

Sequence for the next twelve months

1. Prove the motion. Run pipeline management reviews until conversion by stage is stable across two quarters, and compute sales efficiency. If the number is worse than $1.00, this is the whole project.
2. Get the ARR schedule, the contract register, and margin after services onto a monthly rhythm. Three weeks of work that changes the price of every dollar you raise afterward.
3. Borrow against what the motion returns, sized to twelve months, with covenants set on trailing performance and a modeled downside.
4. Name the one structural change the company needs and cost it honestly. That number, and only that number, is the equity raise.
5. Refinance the facility when ARR has grown enough to reprice it, and use the headroom rather than the cash.

Do that and the dilution question stops being about how to avoid dilution. It becomes a question of what you were willing to sell the company a piece of, which is a question you can answer.